Related Experiment Video
Updated: Jul 6, 2026
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders
Ignacio F Mata1, Ali Samii, Seth H Schneer
1Department of Neurology, University of Washington School of Medicine, Seattle, USA.
Background:
Mutations in the glucocerebrosidase (GBA) gene have been reported to modify risk for Parkinson disease (PD) and dementia with Lewy bodies (DLB). However, these findings have not been consistently replicated, and most studies have had substantial methodological shortcomings.
Objective:
To better assess the role of GBA variants in altering risk for Lewy body disorders.
Design:
Case-control study.
Setting:
Four movement disorder clinics in the Seattle, Washington, area.
Participants:
Seven hundred twenty-one patients with PD, 554 healthy control subjects, and 57 patients with DLB.
Main Outcome Measures:
Disease status and presence or absence of the 2 most common GBA mutations (N370S and L444P).
Results:
We observed a significantly higher heterozygote frequency for the 2 mutations in patients with PD (2.9%; P <.001) and those with DLB (3.5%; P = .045) compared with control subjects (0.4%).
Conclusion:
Our findings suggest that GBA mutations exert a large effect on susceptibility for Lewy body disorders at the individual level but are associated with a modest (approximately 3%) population-attributable risk in individuals of European ancestry.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
01:22Lysosomal Hydrolases
01:24Parkinson Disease l: Introduction
01:11Genetic Lingo
01:29Alzheimer Disease l: Introduction
01:21Huntington Disease l: Introduction